Bettina Hermann

  • Chemistry and Life Sciences
  • Patent Attorney , Partner
  • Munich (DE), Regensburg (DE)
  • +49 89 890636936
  • b.hermann@vo.eu
  • "IP is an essential asset of a company having many different facets – always worth to work for it"
    • Biography

    • IAM recommended individual 2017Bettina Hermann started her career in the IP field in 2001 in a German IP boutique. Bettina studied biology at the Technical University Munich with an emphasis on microbiology, genetics, biochemistry and clinical chemistry. She received her PhD in biology from the Technical University Munich and did practical work at the Max-Planck-Institute of Psychiatry, Munich, before she became Postdoc at the IGBMC in Illkirch Strasbourg, France.

      Bettina has experience in advising small and mid-size biotech companies, in particular in the field of cancer therapies, and providing patentability, validity and FTO analyses for investors. She represents nullity cases before the German Federal Patent Court and is involved in infringement cases before German District Courts.

      Bettina is head of the Munich and Regensburg offices of V.O. She is member of the editorial board of V.O.´s newsletter and member of the steering committee of women in ip e.V.

    • Working experience

    • Patent and Trademark Attorney, V.O. (2008-present)
    • European Litigator, CEIPI (2010-present)
    • Postdoc at the IGBMC in Illkirch Strasbourg, France (1999-2001)
    • Postdoc at the Max-Planck-Institute of Psychiatry (1999)
    • Education

    • PhD, Max-Planck-Institute of Psychiatry in cooperation with the Technical University Munich (1998)
    • Diploma (corresponding to master´s degree) in Biology (1995)
    • Qualifications

    • European Patent Attorney
    • German Patent Attorney
    • Specializations

    • Agreements / contracts
    • Biochemistry
    • Biology
    • Biomarkers
    • Biomedical technology
    • Biotechnology
    • Cell biology and genetics
    • Chemistry
    • Environment
    • Foods
    • Health products
    • Licenses
    • Life Science
    • Lifecycle management
    • Medical diagnostics
    • Medical sciences
    • Medical technology
    • Medicine
    • Medicines
    • Microbiology
    • Nanotechnology
    • Organic chemistry
    • Packaging
    • Pharmaceuticals
    • Supplementary protection certificates (SPC)
    • Vaccines
    • Publications

    • Hermann Bettina (2012): EPO makes two inconsistent decisions. Managing Intellectual Property: Issue 215, p. 88-89
    • Dr. Norman Klix and Dr. Bettina Hermann (2006): Bitter pill for the pharmaceutical industry. Journal of Intellectual Property Law & Practice: Vol. 1, Issue 10, 639-642
    • Bettina Hermann et al. (2000): Pharmacological characterization of cortical gamma-aminobutyric acid type A (GABAA) receptors in two Wistar rat lines selectively bred for high and low anxiety-related behavior. The World Journal of Biological Psychiatry: 1 (3), 137 – 143
    • Christian H.R. Wetzel and Bettina Hermann et al. (1998): Functional Antagonism of Gonadal Steroids at the 5-Hydroxytryptamine Type 3 Receptor. Molecular Endocrinology 12, 1441-1451
    • Latest thinking

    • Biomarker & Companion Diagnostics – Patentierung und Patentstrategien, Martinsried, Germany (October 2012)
    • Düsseldorfer Patentrechtstage (March 2012)
    • GRUR Annual Meeting (September 2012)
    • Marken- und Designschutz – Übersicht, Strategien, Erfahrungen, Munich, Germany (December 2012)
    • Professional & Community Activities

    • women in ip
    • Member of AIPPI (Association International pour la Protection de la Propriété Intellectuelle)
    • Member of FICPI (Fédération Internationale de la Conseils en Propriété Industrielle)
    • Member of LES (Licensing Executives Society)
    • Member of GRUR (German Association for Intellectual Property and Copyright e.V.)
    • Member of epi (European Patent Institute)
    • Member of German Patent Bar Association
    • Languages

    • English
    • French
    • German